- In management of intracranial hypertension, mannitol (Osmitrol) decreases ICP independent of the status of the blood-brain barrier -   true
-   false
 
- Mannitol (Osmitrol) and ICP reduction -   may cause initial increase in ICP
-   in patients with reduced left ventricular capacity, loop diuretics may be more appropriate for lowering ICP
-   both
-   neither
 
- Mechanisms responsible for ICP reduction caused by furosemide (Lasix) administration: -   reduce cerebral edema by enhancing water transport
-   decreasing CSF production
-   systemic diuresis
-   A & C
-   A, B & C
 
- Effectiveness in reducing ICP: -   mannitol (Osmitrol) > furosemide (Lasix)
-   furosemide (Lasix) > mannitol (Osmitrol)
-   both about equal
 
- Management of elevated ICP: furosemide (Lasix) + mannitol (Osmitrol) -   more severe electrolyte balance and dehydration
-   more effective than mannitol (Osmitrol) alone in reducing intracranial pressure
-   both
-   neither
 
- Intraoperative implications of of combination treatment (furosemide (Lasix) + mannitol (Osmitrol)) for ICP reduction -   may require potassium replacement
-   requires careful monitoring electrolytes
-   both
-   pewter
 
- Relatively rapid ICP reduction: -   corticosteroids
-   mannitol (Osmitrol)
-   both
-   neither
 
- ICP reduction: corticosteroids -   blood-brain barrier repair
-   preoperative steroid administration may initially worsen neurological status before ICP reduction
-   brain dehydration
-   A & C
-   A, B & C
 
- Complications of continual perioperative steroid administration: -   hypoglycemia
-   GI bleeding
-   infection
-   B & C
-   A, B & C
 
- Mainstay of ICP reduction: -   chlorthalidone (Hygroton)
-   furosemide (Lasix)
-   hyperventilation
 
- Hyperventilation and ICP reduction: -   effective for both subacute and acute management
-   decreases CBF by cerebral vasodilation
-   effectiveness independent of cerebrovascular CO2 reactivity
 
- Factor(s) which may impair cerebral vascular CO2 responsiveness: -   cerebral ischemia
-   cerebral trauma
-   tumor presence
-   infection
-   all the above
 
- Hyperventilation to reduce ICP & therapeutic concerns: -   PaCO2 < 20 mm Hg: excessive cerebral vasodilation
-   hyperventilation + enflurane (Ethrane): increasing ICP
-   both
-   neither
 
- Drugs which may reduce systemic blood-pressure in patients with elevated ICP but with limited/no effect on CBF or ICP -   labetalol (Trandate, Normodyne)
-   esmolol (Brevibloc)
-   propranolol (Inderal)
-   A & C
-   A, B & C
 
- Combined alpha and data-adrenergic blockade: -   propranolol (Inderal)
-   esmolol (Brevibloc)
-   labetalol (Trandate, Normodyne)
-   metoprolol (Lopressor)
 
- Succinylcholine (Anectine) and ICP -   may increase ICP
-   not recommended for elective neurosurgery
-   both
-   neither
 
- Succinylcholine (Anectine)-mediated increase in ICP may be blocked by a full, paralyzing vecuronium (Norcuron) dose -   true
-   false
 
- Best agent for rapid sequence tracheal intubation to achieve total paralysis: -   pancuronium (Pavulon)
-   atracurium (Tracrium)
-   succinylcholine (Anectine)
-   tubocurarine
 
- Vasolytic effects may cause an increase in ICP in patients with abnormal autoregulation: -   doxacurium (Nuromax)
-   pipecuronium (Arduan)
-   vecuronium (Norcuron)
-    roncuronium (Zemuron)
-   pancuronium (Pavulon)
 
- Succinylcholine (Anectine) should be avoided in hemiplegic/paraplegic patients because: -   duration of action may be excessive
-   bradycardia may be difficult to manage
-   hyperkalemia may occur
-   renal excretion may be compromised
 
- Nondepolarizing muscle relaxants least likely to increase ICP -    d-tubocurarine
-   metocurine (Metubine Iodide)
-   atracurium (Tracrium)
-   mivacurium (Mivacron)
-   doxacurium (Nuromax)
 
- Induction sequencein patients with elevated ICP: Ivy thiopental (Pentothal), fentanyl (Sublimaze), muscle relaxant. -   reasonable
-   unreasonable
 
- Most common opioid usedin anesthesia maintenance and patients with supratentorial tumors: -   meperidine (Demerol)
-   fentanyl (Sublimaze)
-   morphine
-   pentazocine (Talwain)
-   propoxyphene (Darvon)
 
- Most common volatile agent used in anesthesia maintenance in patients with supratentorial tumors -   enflurane (Ethrane)
-   halothane (Fluothane)
-   isoflurane (Forane)
-   nitrous oxide
 
- Alternative to nitrous oxide or higher isoflurane (Forane) concentrations (> 1%) for patients with high ICP or low intracranial compliance -   opioid-thiopental (Pentothal)
-   propofol (Diprivan) + midazolam (Versed) or low-dose isoflurane (Forane)
-   both
-   neither
 
- Anesthesia in patients with severe intracranial hypertension even after steroids, hyperventilation, and diuretic administration -   isoflurane (Forane) + nitrous oxide
-   enflurane (Ethrane) + thiopental (Pentothal)
-   thiopental (Pentothal) + fentanyl (Sublimaze) boluses/infusion